{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:04:24Z","timestamp":1769277864108,"version":"3.49.0"},"reference-count":42,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Quantitative systems pharmacology (QSP) models are rarely applied prospectively for decision-making in clinical practice. We therefore aimed to operationalize a QSP model for potas-sium homeostasis to predict potassium trajectories based on spironolactone administrations. For this purpose, we proposed a general workflow that was applied to electronic health records (EHR) from patients treated in a German tertiary care hospital. The workflow steps included model exploration, local and global sensitivity analyses (SA), identifiability analysis (IA) of model parameters, and specification of their inter-individual variability (IIV). Patient covariates, selected parameters, and IIV then defined prior information for the Bayesian a posteriori prediction of individual potassium trajectories of the following day. Following these steps, the successfully operationalized QSP model was interactively explored via a Shiny app. SA and IA yielded five influential and estimable parameters (extracellular fluid volume, hyperaldosteronism, mineral corticoid receptor abundance, potassium intake, sodium intake) for Bayesian prediction. The operationalized model was validated in nine pilot patients and showed satisfactory performance based on the (absolute) average fold error. This provides proof-of-principle for a Prescribing Monitoring of potassium concentrations in a hospital system, which could suggest preemptive clinical measures and therefore potentially avoid dangerous hyperkalemia or hypokalemia.<\/jats:p>","DOI":"10.3390\/ph17081041","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T07:01:25Z","timestamp":1723100485000},"page":"1041","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-World Application of a Quantitative Systems Pharmacology (QSP) Model to Predict Potassium Concentrations from Electronic Health Records: A Pilot Case towards Prescribing Monitoring of Spironolactone"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3537-3205","authenticated-orcid":false,"given":"Andreas D.","family":"Meid","sequence":"first","affiliation":[{"name":"Internal Medicine IX: Department of Clinical Pharmacology and Pharmacoepidemiology, Medical Faculty Heidelberg\/Heidelberg University Hospital, Heidelberg University, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8569-1694","authenticated-orcid":false,"given":"Camilo","family":"Scherkl","sequence":"additional","affiliation":[{"name":"Internal Medicine IX: Department of Clinical Pharmacology and Pharmacoepidemiology, Medical Faculty Heidelberg\/Heidelberg University Hospital, Heidelberg University, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Metzner","sequence":"additional","affiliation":[{"name":"Internal Medicine IX: Department of Clinical Pharmacology and Pharmacoepidemiology, Medical Faculty Heidelberg\/Heidelberg University Hospital, Heidelberg University, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-5134","authenticated-orcid":false,"given":"David","family":"Czock","sequence":"additional","affiliation":[{"name":"Internal Medicine IX: Department of Clinical Pharmacology and Pharmacoepidemiology, Medical Faculty Heidelberg\/Heidelberg University Hospital, Heidelberg University, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1215-634X","authenticated-orcid":false,"given":"Hanna M.","family":"Seidling","sequence":"additional","affiliation":[{"name":"Internal Medicine IX: Department of Clinical Pharmacology and Pharmacoepidemiology, Medical Faculty Heidelberg\/Heidelberg University Hospital, Heidelberg University, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"},{"name":"Internal Medicine IX: Department of Clinical Pharmacology and Pharmacoepidemiology\u2014Cooperation Unit Clinical Pharmacy, Medical Faculty Heidelberg\/Heidelberg University Hospital, Heidelberg University, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/psp4.12426","article-title":"Quantitative Systems Pharmacology: An Exemplar Model-Building Workflow with Applications in Cardiovascular, Metabolic, and Oncology Drug Development","volume":"8","author":"Helmlinger","year":"2019","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/cpt.528","article-title":"Quantitative Systems Pharmacology: A Case for Disease Models","volume":"101","author":"Musante","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/psp.2014.40","article-title":"Implementation of quantitative and systems pharmacology in large pharma","volume":"3","author":"Visser","year":"2014","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Cucurull-Sanchez, L. An industry perspective on current QSP trends in drug development. J. Pharmacokinet. Pharmacodyn., 2024. in press.","DOI":"10.1007\/s10928-024-09905-y"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/cpt.2443","article-title":"Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot","volume":"111","author":"Lasiter","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cpt.2474","article-title":"The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications","volume":"111","author":"Purpura","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cpt.2480","article-title":"Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design","volume":"111","author":"Dagenais","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1007\/s12325-021-01925-1","article-title":"Determinants of Hyperkalemia Progression Among Patients with Mild Hyperkalemia","volume":"38","author":"Israni","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jamia\/ocw050","article-title":"Developing strategies for predicting hyperkalemia in potassium-increasing drug-drug interactions","volume":"24","author":"Eschmann","year":"2017","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"ref_10","first-page":"w20035","article-title":"Negligible impact of highly patient-specific decision support for potassium-increasing drug-drug interactions\u2014A cluster-randomised controlled trial","volume":"149","author":"Beeler","year":"2019","journal-title":"Swiss Med. Wkly."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/psp4.12755","article-title":"Evaluation framework for systems models","volume":"11","author":"Braakman","year":"2022","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/psp4.12381","article-title":"Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations from the United Kingdom Quantitative and Systems Pharmacology Network","volume":"8","author":"Chappell","year":"2019","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e54428","DOI":"10.2196\/54428","article-title":"Event Analysis for Automated Estimation of Absent and Persistent Medication Alerts: Novel Methodology","volume":"12","author":"Bittmann","year":"2024","journal-title":"JMIR Med. Inf."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10928-022-09815-x","article-title":"A quantitative systems pharmacology model of plasma potassium regulation by the kidney and aldosterone","volume":"49","author":"Maddah","year":"2022","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/j.1552-4604.1989.tb03339.x","article-title":"Spironolactone metabolism: Steady-state serum levels of the sulfur-containing metabolites","volume":"29","author":"Gardiner","year":"1989","journal-title":"J. Clin. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2125.1982.tb01413.x","article-title":"Spironolactone dose-response relationships in healthy subjects","volume":"13","author":"McInnes","year":"1982","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Blanco, J.S., and Lanao, J.M. (2022). Model-Informed Precision Dosing (MIPD). Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14122731"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-pharmtox-033020-113257","article-title":"Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy","volume":"61","author":"Darwich","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/psp4.12353","article-title":"Model-Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities","volume":"7","author":"Keizer","year":"2018","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1093\/ndt\/gfaa232","article-title":"Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease?","volume":"36","author":"Ramos","year":"2021","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.1.06017","article-title":"The new biology of aldosterone","volume":"186","author":"Connell","year":"2005","journal-title":"J. Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/01.HYP.0000149431.79450.a2","article-title":"Plasma sodium: Ignored and underestimated","volume":"45","author":"He","year":"2005","journal-title":"Hypertension"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.vh.2018.07.001","article-title":"Regulation of Aldosterone Secretion","volume":"109","author":"MacKenzie","year":"2019","journal-title":"Vitam. Horm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/cpt.1780","article-title":"Real-World Data and Physiologically-Based Mechanistic Models for Precision Medicine","volume":"107","author":"Wang","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1029\/2000WR900350","article-title":"Practical identifiability analysis of large environmental simulation models","volume":"37","author":"Brun","year":"2001","journal-title":"Water Resour. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/00401706.1999.10485594","article-title":"A Quantitative Model-Independent Method for Global Sensitivity Analysis of Model Output","volume":"41","author":"Saltelli","year":"1999","journal-title":"Technometrics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100609","DOI":"10.1016\/j.softx.2020.100609","article-title":"pksensi: An R package to apply global sensitivity analysis in physiologically based kinetic modeling","volume":"12","author":"Hsieh","year":"2020","journal-title":"SoftwareX"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/psp4.12758","article-title":"Predicting model-informed precision dosing: A test-case in tacrolimus dose adaptation for kidney transplant recipients","volume":"11","author":"Faelens","year":"2022","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.compchemeng.2014.07.025","article-title":"Model predictive control of anesthesia under uncertainty","volume":"71","author":"Krieger","year":"2014","journal-title":"Comput. Chem. Eng."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00228-018-2513-6","article-title":"Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: A systematic review","volume":"74","author":"Saeheng","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/psp4.12052","article-title":"A Tutorial on RxODE: Simulating Differential Equation Pharmacometric Models in R","volume":"5","author":"Wang","year":"2016","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18637\/jss.v033.i09","article-title":"Solving Differential Equations in R: Package deSolve","volume":"33","author":"Soetaert","year":"2010","journal-title":"J. Stat. Softw."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Leven, C., Coste, A., and Man\u00e9, C. (2022). Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14020442"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/psp4.12056","article-title":"A model qualification method for mechanistic physiological QSP models to support model-informed drug development","volume":"5","author":"Friedrich","year":"2016","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/psp4.12071","article-title":"A Six-Stage Workflow for Robust Application of Systems Pharmacology","volume":"5","author":"Gadkar","year":"2016","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Sher, A., Niederer, S.A., Mirams, G.R., Kirpichnikova, A., Allen, R., Pathmanathan, P., Gavaghan, D.J., van der Graaf, P.H., and Noble, D. (2022). A Quantitative Systems Pharmacology Perspective on the Importance of Parameter Identifiability. Bull. Math. Biol., 84.","DOI":"10.1007\/s11538-021-00982-5"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.18637\/jss.v033.i03","article-title":"Inverse Modelling, Sensitivity and Monte Carlo Analysis in R Using Package FME","volume":"33","author":"Soetaert","year":"2010","journal-title":"J. Stat. Softw."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Hsieh, N.H., Reisfeld, B., Bois, F.Y., and Chiu, W.A. (2018). Applying a Global Sensitivity Analysis Workflow to Improve the Computational Efficiencies in Physiologically-Based Pharmacokinetic Modeling. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00588"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/psp4.6","article-title":"Sobol Sensitivity Analysis: A Tool to Guide the Development and Evaluation of Systems Pharmacology Models","volume":"4","author":"Zhang","year":"2015","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3800(01)00256-3","article-title":"Biogeochemical model of Lake Z\u00fcrich: Model equations and results","volume":"141","author":"Omlin","year":"2001","journal-title":"Ecol. Model."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med. Care"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Lee, T.C., Shah, N.U., Haack, A., and Baxter, S.L. (2020). Clinical Implementation of Predictive Models Embedded within Electronic Health Record Systems: A Systematic Review. Informatics, 7.","DOI":"10.3390\/informatics7030025"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/8\/1041\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:31:37Z","timestamp":1760110297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/8\/1041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ph17081041"],"URL":"https:\/\/doi.org\/10.3390\/ph17081041","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]}}}